Toews Corp Pfizer Inc Transaction History

Toews Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	BUY	$32.09 - $37.51 $786,205 - $918,995	24,500 New	24,500 $812,000
Q4 2021 Jan 27, 2022	SELL	$41.32 - $61.25 $392,540 - $581,875	-9,500 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$39.25 - $50.42 $372,875 - $478,990	9,500 New	9,500 $409,000
Q2 2021 Aug 02, 2021	SELL	$35.91 - $40.68 $937,250 - $1.06 Million	-26,100 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$33.49 - $37.77 $874,089 - $985,797	26,100 New	26,100 $946,000
Q4 2020 Feb 03, 2021	SELL	$33.47 - $42.56 $907,037 - $1.15 Million	-27,100 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $860,425 - $1.01 Million	27,100 New	27,100 $995,000
Q1 2019 Jun 14, 2019	SELL	$37.5 - $41.2 $918,750 - $1.01 Million	-24,500 Closed	0 $0
Q4 2018 Jun 20, 2019	BUY	$38.47 - $43.86 $942,515 - $1.07 Million	24,500 New	24,500 $1.07 Million
Q3 2018 Jun 20, 2019	SELL	$34.47 - $41.81 $365,382 - $443,186	-10,600 Closed	0 $0
Q2 2018 Jun 20, 2019	SELL	$32.98 - $35.16 $557,362 - $594,204	-16,900 Reduced 61.45%	10,600 $385,000
Q1 2018 Jun 21, 2019	BUY	$31.91 - $37.02 $877,525 - $1.02 Million	27,500 New	27,500 $976,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Toews Corp , based on Form 13F filings with the SEC.

Stay updated on Toews Corp with notifications on news.